Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Complement Factor P (CFP) (N-Term) Peptid

CFP Reaktivität: Human Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN974876

Kurzübersicht für Complement Factor P (CFP) (N-Term) Peptid (ABIN974876)

Target

CFP (Complement Factor P (CFP))

Spezies

Human

Quelle

  • 3
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein Region

    N-Term

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-CFP antibody (Catalog #: ARP56381_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CFP (Complement Factor P (CFP))

    Hintergrund

    CFP is a plasma glycoprotein that positively regulates the alternative complement pathway of the innate immune system. This protein binds to many microbial surfaces and apoptotic cells and stabilizes the C3- and C5-convertase enzyme complexes in a feedbac

    Alias Symbols: BFD, PFC, PFD, PROPERDIN

    Protein Interaction Partner: C3,CFB,C3,CFB,MTOR

    Protein Size: 469

    Molekulargewicht

    48 kDa

    Gen-ID

    5199

    NCBI Accession

    NM_002621, NP_002612

    UniProt

    P27918
Sie sind hier:
Chat with us!